The End Drug Shortages Alliance, a nonprofit formed by Vizient in 2021 to address medication supply chain issues, has named four new members to its board, including Ascension’s chief pharmacy officer. The organization announced Jan. 22 that its new board…
Pharmacy
CVS Health reported progress on key affordability and access initiatives, including reduced prior authorization burdens and expanded biosimilar adoption. The company has about half as many medical services subject to prior authorization as its nearest competitor, according to a Jan.…
The House Judiciary Committee in an interim staff report accuses CVS Health of restricting independent pharmacies from working with digital pharmacy competitors to protect its market position. The report, issued Jan. 21 and titled “When CVS Writes the Rules: How…
The FDA will begin accepting applications Feb. 1 for its PreCheck pilot program, an initiative designed to strengthen the domestic pharmaceutical supply chain. The program aims to increase regulatory predictability and streamline facility assessments for new U.S.-based pharmaceutical manufacturing sites,…
Six national pharmacy organizations voiced strong support for the Consolidated Appropriations Act of 2026, which includes the first major pharmacy benefit manager reform in Medicare Part D in nearly 20 years. The bill is part of a broader $1.2 trillion…
Advertisement
CVS Health and the University of Maryland School of Pharmacy in Baltimore launched a multiyear collaboration to strengthen pharmacy workforce development and advance innovation in community practice. The partnership will support the school’s efforts to explore and implement an AI-driven…
The FDA has granted Regenerative Medicine Advanced Therapy designation to NouvNeu001, a cell therapy for Parkinson’s disease. NouvNeu001, developed by iRegene, is the first allogeneic cell therapy globally to hold both RMAT and Fast Track designations, according to a Jan.…
As access to retail pharmacy services has grown more fragmented since the COVID-19 pandemic, Charlottesville, Va.-based UVA Health has leaned into system-owned pharmacies as a core part of care continuity by expanding locations, staffing and service models to meet patient…
The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft guidance outlines recommendations for trial design, statistical methods and…
Enable more effective and targeted treatments that address unique needs for patients with pharmacogenomics. The traditional one-size-fits-all approach to medication has long been recognized as a limitation in healthcare, often resulting in suboptimal treatment outcomes, adverse drug reactions, and compromised…